Status:
UNKNOWN
Ventriculo-arterial Coupling Modification Evaluated by PRAM During TAVI Procedure
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Aortic Valve Stenosis
Ventricular Dysfunction, Left
Eligibility:
All Genders
18+ years
Brief Summary
Calcified aortic stenosis is the most frequent valvulopathy in Europe and North America. Aortic stenosis is an obstacle to the ejection of blood from the left ventricle to the aorta and leads to morph...
Eligibility Criteria
Inclusion
- Age \>18 years
- elective TAVI intervention with femoral access
- consent
Exclusion
- permanent arrhythmias
- pacemaker dependency
- moderate to severe mitral or tricuspid valve regurgitation
- intracardiac shunt
Key Trial Info
Start Date :
September 14 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03385785
Start Date
September 14 2017
End Date
November 1 2018
Last Update
December 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
FRITZ
Nancy, France, 54000